E1.Initial reporter phone: (b)(6).The bwi product analysis lab received the device for evaluation on 07-feb-2024.The device evaluation was completed on 04-mar-2024.The device was returned to biosense webster (bwi) for evaluation.A visual inspection and screening test of the returned device were performed following bwi procedures.Visual analysis of the returned sample revealed reddish material inside the pebax, and a separation between the electrode 3 and the pebax.The magnetic and force features were tested and no errors were observed.The force values and the vector were observed within specifications.No force issues were observed.The blood found inside the pebax area may contribute to the force and magnetic issue reported.The root cause of the separation in the pebax could be related to the handling of the device during the procedure; however, this cannot be conclusively determined.A manufacturing record evaluation was performed and no internal action was found during the review.The issue reported by the customer was confirmed.The instructions for use contain the following information that should be considered: to ensure accurate force readings, verify that the force reading is near zero when the catheter is not in contact with tissue.If the force reading is not near zero when the catheter is not in contact with tissue, perform zeroing.As part of biosense webster's quality process, all devices are manufactured, inspected, and released to approved specifications.This product issue will be addressed through bwi's quality system.Manufacturer¿s reference number: (b)(4).
|
It was reported that a patient underwent a pvc procedure with a thermocool® smart touch¿ electrophysiology catheter for which biosense webster¿s product analysis lab (pal) identified a separation between the electrode 3 and the pebax.Initially an error 106 was reported.The 106 alert code occurred after the catheter was plugged into the carto and before the first ablation as tip threaded through distal end of sheath (distal exit).A second device was used to complete the procedure.There was no adverse event reported on the patient.Catheter was not used in patient.The biosense webster, inc.Product analysis lab received the device for evaluation and per the evaluation completion on 04-mar-2024, observed reddish material inside the pebax, and a separation between the electrode 3 and the pebax.The event was originally considered non-reportable, however, bwi became aware of a separation between the electrode 3 and the pebax on 04-mar-2024 and have assessed this returned condition as reportable.
|